Arkady Mayblyum serves as an Associate Director ? MES Services, managing Aztec Technologies Foxboro, MA office. Over his professional carrier Arkady provided computer consulting services for multiple biotech and pharmaceutical companies. His expertise encompasses a broad range of computer and control systems used in FDA-regulated industries as well as computer system validation and project management.

Arkady holds a degree from Moscow State Automobile and Road Technical Institute (State Technical University) (MADI), Moscow, Russia

Virgil Sufariu is responsible for the design and implementation of Rockwell based projects at Aztec Technologies. With a background in mechanical engineering and automation systems, his goal is to advance new ideas and to improve performance of the implemented systems. As a seasoned automation engineer and a strong work ethic, he has experience that touches multiple engineering fields: electrical, mechanical, software, IT, etc. Besides working on exciting and innovative projects, one of his favorite parts of the job is interacting with customers and being in the field, testing Aztec?s latest projects.

Prior to Aztec, Virgil spent nearly two decades with a power generation services company, specializing in automating emission control systems for coal burning power plants and the first concentrated solar thermal power plant in US. He holds an B.S. in Automation and Mechanical Engineering from the University of Transilvania in Brasov, Romania.

Robert Sussman, Ph.D., DABT, is Managing Director of Trinity’s SafeBridge Regulatory & Life Sciences Group that provides environmental health and safety services to pharmaceutical, chemical, biotechnology and other industries. With more than 30 years of experience, he is a recognized expert in the evaluation of occupational hazards of potent pharmaceutical compounds and has delivered numerous papers and lectures on the subject. Dr. Sussman has extensive experience in performing risk assessments including evaluating toxicological and exposure information to determine potential health effects of chemicals, presenting toxicological data to regulatory agencies and assessing the potential impact of environmental, health and safety regulations on chemical and pharmaceutical companies, evaluating safe levels for product cross-contamination by drug substances or other chemicals, and the testing of chemicals for their toxic effects and the interpretation of data from these tests. Dr. Sussman has provided clients with the practical aspects of applying toxicological data to worker and consumer exposure situations for potent and toxic compounds handled in the workplace. He has provided training and technical support to diverse audiences to meet regulatory requirements and to provide solutions to their environmental health and safety challenges.

He has worked in various capacities in corporate occupational toxicology groups culminating as a Director of Occupational Toxicology in Pfizer’s Corporate Environmental Health and Safety Department. His group was responsible for evaluating the toxicity of pharmaceutical products, their intermediates and other chemicals handled in research facilities and providing hazard communication information to all research facilities worldwide.

Bob has an Sc.B. in Bioenvironmental Engineering from Brown University and a Ph.D. in Environmental Health Science from New York University. He is a Diplomate of the American Board of Toxicology, a past member and chair of the AIHA’s WEEL Committee, and a founding member of the Occupational Toxicology Roundtable and serves on that organization’s steering committee. Bob is also a member of the Society of Toxicology, American Industrial Hygiene Association, and the International Society of Pharmaceutical Engineers. He has had an adjunct appointment at the NYU Medical Center where he gives several lectures each year on regulatory toxicology, risk assessment, and industrial hygiene aspects of the pharmaceutical industry.

Areas of Expertise:

• Occupational toxicology
• Risk assessment and hazard communication
• Product safety and cross-contamination

Certifications:

• Diplomate, American Board of Toxicology

Allan Ader, Ph.D., DABT, Managing Director of Trinity’s SafeBridge Regulatory and Life Sciences Group, has over 30 years’ experience in toxicology, risk assessment and industrial hygiene. He has an extensive background in evaluating complex environmental, health and safety issues and in developing solutions and programs. Dr. Ader has experience in:

Developing Occupational Exposure Limits and assessing compounds for toxicity and potency for compound categorization / banding and recommending handling practices and controls based on the toxicity/potency characteristics;
Assisting companies in testing of chemicals for their toxic effects and interpreting data from these tests,
Performing risk assessments including evaluating toxicological and exposure information to determine potential health effects of chemicals, and
Responding to crises caused by occupational health illnesses from chemicals by assessing and evaluating risks and communicating them to employees and management.
His pharmaceutical and chemical industry experience includes working for Syntex, Inc. in Palo Alto, CA and Olin Corporation, New Haven, CT. He received a Ph.D. in Industrial Health (Toxicology) from the University of Michigan and an M.S. in Industrial Hygiene from Temple University. He is a Diplomate of the American Board of Toxicology.

Areas of Expertise:

• Occupational toxicology
• Industrial hygiene
• Risk assessment and communication
• Regulatory management
• Product safety

Certifications:

• Diplomate, American Board of Toxicology

Albert Dyrness is the Divisional President, Life Sciences. This pillar provides engineering and compliance solutions to the life science industry. Albert has more than 20 years of experience in process engineering design, and commissioning of GMP equipment, systems, and facilities.

Albert is a member of the American Society of Mechanical Engineers Bioprocess Equipment (ASME BPE) Standards Committee and is serving as the Chairperson for the ASME BPE System Design subcommittee. He is a past board member of Oncobiologics (now Outlook Therapeutics), a NASDAQ-traded clinical stage biopharmaceutical company. He is also an Industrial Advisory Board Member of the University of the Pacific?s Bioengineering program.

Albert received an M.S. in Mechanical Engineering from Massachusetts Institute of Technology. He holds professional engineering licenses in the state of California for Chemical Engineering and Mechanical Engineering.